TGFB1 and Hepatic fibrosis: In addition, research results have shown that RPR has anti-hepatic fibrosis efficacy, and its mechanism may be related to its blocking of the TGF-β1/Smad signaling pathway, providing novel mechanisms for the treatment of liver fibrosis (Gao et al., 2012).